These variables, including programmed death ligand 1 (PD-L1) expression, tumour mutational load (TMB), microsatellite instability (MSI) status, gut microbiota, and a number of other markers, may be able to predict the outcome for a portion of patients, according to previous research (14, 15). This evidence concerns the gene CD274 and neoplasm.